MEEDER ASSET MANAGEMENT INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 193 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$1,000
-90.0%
110
-74.0%
0.00%
-100.0%
Q4 2019$10,000423
+5942.9%
0.00%
Q3 2019$070.0%0.00%
Q2 2019$0
-100.0%
7
-95.0%
0.00%
Q2 2018$5,478,000
+91200.0%
141
-65.4%
0.00%
-100.0%
Q1 2017$6,000
+20.0%
407
+2.0%
0.00%
Q4 2016$5,0003990.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders